Clinical Trial
Piroxicam versus naproxen in rheumatoid arthritis: a double-blind, cross-over study
- PMID: 3888863
Item in Clipboard
Clinical Trial
Piroxicam versus naproxen in rheumatoid arthritis: a double-blind, cross-over study
Int J Clin Pharmacol Res.
1985.
Abstract
Piroxicam 20 mg daily was compared with naproxen 1000 mg daily in a double-blind cross-over study of 24 patients with rheumatoid arthritis. A comparison was also made with the pre-trial medication. The effect of the pre-trial medication, piroxicam and naproxen, were found to be similar. The side-effects of piroxicam and naproxen were similar and mild.
Similar articles
-
Naproxen and piroxicam. A comparative trial in rheumatoid arthritis.Eur J Rheumatol Inflamm. 1983;6(3):242-6. Eur J Rheumatol Inflamm. 1983. PMID: 6239778
-
Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study.Pharmatherapeutica. 1985;4(2):113-21. Pharmatherapeutica. 1985. PMID: 3903778 Clinical Trial.
-
Double-blind evaluation of piroxicam and naproxen following missed dosage in patients with inflammatory arthritis.N Z Med J. 1985 Jun 26;98(781):490-2. N Z Med J. 1985. PMID: 3892383 Clinical Trial.
-
Isoxicam.Clin Rheum Dis. 1984 Aug;10(2):385-99. Clin Rheum Dis. 1984. PMID: 6391795 Review. No abstract available.
-
Update on ibuprofen for rheumatoid arthritis.Am J Med. 1984 Jul 13;77(1A):3-9. doi: 10.1016/s0002-9343(84)80012-1. Am J Med. 1984. PMID: 6380279 Review.
Cited by
-
Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.Drugs. 1990 Jul;40(1):91-137. doi: 10.2165/00003495-199040010-00006. Drugs. 1990. PMID: 2202585 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical